| Drug Name | amcasertib |
|---|---|
| Other Drug Names | BB-503; BBI-503; GB-503; amcasertib |
| Chemical Name | N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-{[2-oxo-5-(2-phenyl-1,3-thiazol-4-yl)-1,2-dihydro-3H-indol-3-ylidene]methyl}-1H-pyrrole-3-carboxamide |
| Formula | C31H33N5O2S |
| Mol. Wt. | 539.7 |
| CAS No. | 1129403-56-0 |
| UNII | GLY8ABW25V |
| Target-based Actions | Stem cell |
| Highest Status | Phase 2 Clinical |
| Originator Company | Boston Biomedical Inc |
| Structure |
 |
Extended Information